Timeline
Genflow to present gene therapy data at Toronto longevity summit
Genflow Biosciences highlights progress with focus on R&D
Health & Bio Today: GSK, AstraZeneca, Hemogenyx Pharmaceuticals, Genflow Biosciences
Genflow Biosciences shares higher as 'tier-1' talks advance
Genflow Biosciences secures fully funded LNP collaboration with Acuitas Therapeutics
Genflow’s SIRT6 patent fence widens
Genflow says its gene therapy for dogs maintains safety and efficacy three months after dosing
More in Pharma
Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer
Positive overall survival data from a China trial of risvutatug rezetecan marks the first Phase III success for any B7-H3-targeted antibody-drug conjugate, strengthening GSK's broader development programme.